login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
INSMED INC (INSM) Stock News
NASDAQ:INSM -
US4576693075
-
Common Stock
136.1
USD
+1.13 (+0.84%)
Last: 8/29/2025, 8:00:02 PM
136.1
USD
0 (0%)
After Hours:
8/29/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INSM Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Benzinga
- Mentions:
SPY
ISRG
MSFT
ORCL
...
Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2
10 days ago - By: Benzinga
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
10 days ago - By: Insmed Incorporated
Insmed To Present at September Investor Conferences
12 days ago - By: Yahoo Finance
- Mentions:
UNH
AAPL
This ‘Strong Buy’ Pharma Stock Is Surging to New Highs
15 days ago - By: Yahoo Finance
- Mentions:
UNH
CNC
OSCR
ELV
...
Solar, biotech, and health insurance stocks are rising on Friday: here's why
18 days ago - By: Yahoo Finance
- Mentions:
DB
JPM
GS
AKAM
...
C3 AI downgraded, Capri upgraded: Wall Street's top analyst calls
19 days ago - By: Investor's Business Daily
- Mentions:
LLY
Top 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval
19 days ago - By: Bloomberg
Insmed Drug Wins First US Approval for Debilitating Lung Disease
19 days ago - By: Insmed Incorporated
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
20 days ago - By: Zacks Investment Research
Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock
24 days ago - By: Zacks Investment Research
Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
24 days ago - By: Zacks Investment Research
- Mentions:
ARCT
Insmed (INSM) Reports Q2 Loss, Beats Revenue Estimates
24 days ago - By: Insmed Incorporated
Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update
25 days ago - By: Zacks Investment Research
- Mentions:
FTRE
Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates
26 days ago - By: Zacks Investment Research
Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
a month ago - By: Yahoo Finance
Insmed’s Pipeline Growth With Brensocatib Approval And Phase 3 Trials
a month ago - By: Yahoo Finance
Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2
a month ago - By: Investor's Business Daily
- Mentions:
UTHR
LQDA
Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work?
a month ago - By: Insmed Incorporated
Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025
Please enable JavaScript to continue using this application.